Senator Hassan Seeks Analysis of Public Health Consequences of mRNA Research Cuts

Strategic Insights -

U.S. Senator Maggie Hassan is requesting an independent analysis of the potential health and economic costs of Health and Human Services Secretary Robert F. Kennedy Jr.'s abrupt cancellation of nearly $500 million in mRNA-related research and development contracts. Senator Hassan is concerned about the impacts of the Secretary's decision, especially for Americans of all ages who live with cancer and other diseases that could soon be treated or even cured with mRNA. The mRNA vaccine platform has shown tremendous potential in treating and preventing diseases, including cancer, and Senator Hassan is seeking a comprehensive assessment of how Secretary Kennedy's abandonment of mRNA research could impact American lives and health.

Key Takeaways:

  • Senator Hassan is requesting an independent analysis of the public health consequences of Secretary Kennedy's decision to cancel mRNA research and development contracts.
  • The cancellation of $500 million in mRNA research and development contracts could impact Americans' lives and health, particularly for those living with cancer and other diseases.
  • The mRNA vaccine platform has shown potential in treating and preventing diseases, including cancer, with recent clinical advancements demonstrating its ability to reduce relapse rates and improve outcomes for patients.
  • If HHS follows through on its plan to fully divest from the mRNA vaccine platform, Americans will likely lose out on cures for deadly diseases and critical protection from future biological attacks and pandemics.
  • Senator Hassan has spoken out against Secretary Kennedy's abandonment of mRNA research, citing his history of promoting anti-vaccine conspiracy theories and lack of knowledge about the basics of healthcare programs.
  • The Senator is seeking answers to specific questions about the financial and human costs of the United States abandoning the mRNA vaccine platform, including:

+ For which cancers could the United States have mRNA vaccines or immunotherapy treatments available in the near future?

+ In the coming years, approximately how many lives could be saved in the United States using mRNA vaccines and immunotherapies?

+ What would be the economic cost to the United States of ceasing government investment in the mRNA platform?

+ How many deaths have been prevented in the United States as a result of immunizations with the mRNA COVID-19 vaccines?

  • Senator Hassan is also pushing for an investigation into Secretary Kennedy's handling of the mRNA research cancellation and its potential impacts on public health.

Statistics:

  • The cancellation of $500 million in mRNA research and development contracts is a significant setback for the development of treatments and cures for deadly diseases, including cancer.
  • Recent clinical advancements have shown that mRNA vaccines can reduce relapse rates and improve outcomes for patients with cancer.
  • According to clinical trials, mRNA vaccines have shown tremendous potential in treating a range of diseases, including melanoma, brain, pancreatic, and lung cancers.
  • The mRNA COVID-19 vaccines have prevented an estimated number of deaths in the United States.
  • The economic cost to the United States of ceasing government investment in the mRNA platform is estimated to be in dollar terms.

Sources:

  • [Senator Hassan's News Release](https://www.hassan.senate.gov/news/press-releases/senator-hassan-seeks-analysis-of-public-health-consequences-of-secretary-kennedys-mrna-research-cuts)
  • [August 5, 2025, U.S. Department of Health and Human Services Press Release](original text reference not provided)